This article highlights the current controversies around stem cell research and its application in clinical medicine. It aims to discuss the ethical concerns around how corporate involvement is corrupting the ethical progression in this field of research. The author appeals to medical and scientific communities to take cognisance of current practices and to facilitate the regulation of new stem cell therapies being advertised to the public.
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher's Version
- Health and Medical Publishing Group Publisher's website
- South African Journal of Bioethics and Law Journal website
- Publication date:
- Pubs id:
- Local pid:
- Copyright holder:
- Health and Medical Publishing Group
- Copyright date:
- © 2014 Health and Medical Publishing Group. This journal is protected by a Creative Commons Attribution - NonCommercial Works License (CC BY-NC 4.0)
The battle against stem cell hype: are we doing enough? can the medical and scientific community do more to support regulatory boards in advocating ethical evidence-based medicine?
If you are the owner of this record, you can report an update to it here: Report update to this record